Core Scientific, Inc.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-1.16B | $-347.2M | $216.0M | $-144.0M | $-936.8M | $576.3M | $-291.1M | $-455.3M |
| Depreciation & Amortization | $15.5M | $16.6M | $14.1M | $16.3M | $18.8M | $19.7M | $26.0M | $28.7M |
| Depreciation | $15.3M | $16.4M | — | — | $18.6M | $19.5M | — | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $18.2M | $17.8M | $27.9M | $29.9M | $24.2M | $16.2M | $24.0M | $20.5M |
| Net Cash from Operating Activities | $-18.9M | $249.9M | $157.5M | $131.8M | $34.0M | $-45.0M | $13.8M | $5.7M |
| Investing Activities | ||||||||
| Capital Expenditures | $565.0M | $389.2M | $279.2M | $244.5M | $121.3M | $84.0M | $28.8M | $31.2M |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-796.2M | $-386.7M | $-277.8M | $-254.4M | $-119.6M | $-89.0M | $-28.8M | $-31.2M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $2.22B | $971.4M | $-21.8M | $-5.3M | $-31.8M | $-4.2M | $598.2M | $182.2M |
| Net Change in Cash | $1.41B | $834.6M | $-142.1M | $-127.9M | $-117.4M | $-138.3M | $583.2M | $156.7M |
| Free Cash Flow | $-583.9M | $-139.3M | $-121.7M | $-112.7M | $-87.3M | $-129.0M | $-15.0M | $-25.5M |